Adermatoglyphia
| Adermatoglyphia | |
|---|---|
| Synonyms | Immigration delay disease |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Absence of fingerprints, reduced number of sweat glands |
| Complications | None |
| Onset | Birth |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the SMARCAD1 gene |
| Risks | |
| Diagnosis | Genetic testing, Dermatoglyphics |
| Differential diagnosis | Naegeli–Franceschetti–Jadassohn syndrome, Dermatopathia pigmentosa reticularis |
| Prevention | N/A |
| Treatment | None required |
| Medication | N/A |
| Prognosis | Excellent |
| Frequency | Very rare |
| Deaths | N/A |
A rare genetic disorder affecting fingerprints
Adermatoglyphia[edit]

Adermatoglyphia is a rare genetic disorder characterized by the absence of dermatoglyphics, which are the ridges on the skin of the fingers, palms, toes, and soles. This condition is often referred to as "immigration delay disease" because individuals with adermatoglyphia lack fingerprints, which can complicate identity verification processes.
Genetics[edit]
Adermatoglyphia is inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder. The condition is associated with mutations in the SMARCAD1 gene, which plays a role in the development of skin ridges during embryonic development.
Clinical Features[edit]
Individuals with adermatoglyphia typically have:
- Absence of fingerprints
- Normal sweat gland function
- No other significant skin abnormalities
The lack of fingerprints is the primary clinical feature, and there are usually no other health issues associated with the condition.
Diagnosis[edit]
Diagnosis of adermatoglyphia is primarily based on the clinical observation of absent fingerprints. Genetic testing can confirm the presence of mutations in the SMARCAD1 gene. Family history can also provide clues, as the condition is inherited in an autosomal dominant manner.
Management[edit]
There is no treatment required for adermatoglyphia, as it does not cause any health problems. Management focuses on addressing the practical issues related to the absence of fingerprints, such as difficulties with biometric identification.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian